Catherine Novack
Stock Analyst at Jones Trading
(0.51)
# 4,095
Out of 4,996 analysts
20
Total ratings
23.53%
Success rate
-14.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $13.15 | +128.14% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $7.09 | +309.03% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.36 | +1,567.59% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.55 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $59.59 | -24.48% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.11 | +421.33% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $40.66 | +219.72% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $1.50 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $6.80 | +135.29% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $5.10 | +174.78% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.09 | +522.01% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $9.34 | +7.07% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $3.08 | +614.29% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.65 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $0.60 | +26,588.91% | 1 | Jul 21, 2023 |
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $13.15
Upside: +128.14%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $7.09
Upside: +309.03%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.36
Upside: +1,567.59%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.55
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $59.59
Upside: -24.48%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.11
Upside: +421.33%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $40.66
Upside: +219.72%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.50
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $6.80
Upside: +135.29%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $5.10
Upside: +174.78%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.09
Upside: +522.01%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $9.34
Upside: +7.07%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $3.08
Upside: +614.29%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.65
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $0.60
Upside: +26,588.91%